Literature DB >> 7404497

An objective study of alternative methods of heparin administration.

P G Bentley, V V Kakkar, M F Scully, I R MacGregor, P Webb, P Chan, N Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7404497     DOI： 10.1016/0049-3848(80)90182-6

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  12 in total

1.  Coronary thrombolysis: round two and beyond.

Authors:  R G Wilcox
Journal:  Br Heart J       Date:  1991-04

Review 2.  Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.

Authors:  Lindsay Robertson; James Strachan
Journal:  Cochrane Database Syst Rev       Date:  2017-02-14

3.  Anticoagulants in venous thromboembolism.

Authors:  M D Stringer; N Wilson; V V Kakkar
Journal:  BMJ       Date:  1989-01-21

Review 4.  Anticoagulants in venous thromboembolism.

Authors:  A Fennerty; I A Campbell; P A Routledge
Journal:  BMJ       Date:  1988-11-19

5.  The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: second revision. BCSH Haemostasis and Thrombosis Task Force.

Authors:  B T Colvin; T W Barrowcliffe
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

6.  Management of pulmonary embolism.

Authors:  C V Ruckley
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-25

7.  Risk of complications during intravenous heparin therapy.

Authors:  P H Nelson; K M Moser; C Stoner; K S Moser
Journal:  West J Med       Date:  1982-03

Review 8.  Pharmacokinetic optimisation of the treatment of deep vein thrombosis.

Authors:  A Iorio; G Agnelli
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

9.  Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective randomised trial.

Authors:  M G Walker; J W Shaw; G J Thomson; J G Cumming; M L Thomas
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-09

Review 10.  Heparin therapy. Regimens and treatment considerations.

Authors:  T M Hyers
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.